Reaction
Therapeutic Embolisation reporting signals
As of the last recalculation, Therapeutic Embolisation appears in 311 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is SOFOSBUVIR (PRR 72.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sofosbuvir | 20 | 72.4 | 72.5 |
| Epoprostenol | 10 | 52.8 | 52.8 |
| Sorafenib | 14 | 47.2 | 47.2 |
| Entecavir | 8 | 47.0 | 47.1 |
| Lanreotide Acetate | 5 | 43.4 | 43.4 |
| Bosentan | 20 | 28.3 | 28.3 |